Deborah Layton
Impact in
- Toxicology top 1%
- Pharmacovigilance and Adverse Drug Reactions
- Pharmacology top 5%
- Inflammatory mediators and NSAID effects
- Drug-Induced Adverse Reactions
- Pharmacogenetics and Drug Metabolism
Papers in
- Pharmacology 15
- Inflammatory mediators and NSAID effects 11
- Pharmacogenetics and Drug Metabolism 3
- Pharmaceutical industry and healthcare 2
- Toxicology 15
- Pharmacovigilance and Adverse Drug Reactions 15
- Co-authors
- Saad Shakir (43 shared papers)Lynda V. Wilton (7 shared papers)Gillian Pearce (3 shared papers)Emma Heeley (2 shared papers)David W. J. Clark (2 shared papers)Lynda Wilton (5 shared papers)Scott Harris (3 shared papers)Vicki Osborne (10 shared papers)
- Journals
- Drug Safety (27 papers)Pharmacoepidemiology and Drug Safety (7 papers)British Journal of Clinical Pharmacology (3 papers)European Psychiatry (2 papers)European Journal of Clinical Pharmacology (2 papers)
- Partner nations
- United KingdomNetherlandsUnited States
In The Last Decade
Deborah Layton
61 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 114
- Toxicology 183
- Pharmacology 248
- Geriatrics and Gerontology 27
- Psychiatry and Mental health 104
- Pharmacology 64
Countries citing papers authored by Deborah Layton
This map shows the geographic impact of Deborah Layton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah Layton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah Layton more than expected).
Fields of papers citing papers by Deborah Layton
This network shows the impact of papers produced by Deborah Layton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah Layton. The network helps show where Deborah Layton may publish in the future.
Co-authors
The 25 scholars most cited alongside Deborah Layton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 64 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 97 | |
| 2 | 2002 | 79 | |
| 3 | 2001 | 52 | |
| 4 | 2003 | 46 | |
| 5 | 2004 | 43 | |
| 6 | 2020 | 42 | |
| 7 | 2005 | 40 | |
| 8 | 2011 | 37 | |
| 9 | 2003 | 35 | |
| 10 | 2006 | 32 | |
| 11 | 2002 | 31 | |
| 12 | 2001 | 29 | |
| 13 | 1996 | 28 | |
| 14 | 2003 | 26 | |
| 15 | 2006 | 26 | |
| 16 | 2002 | 25 | |
| 17 | 2011 | 25 | |
| 18 | 2010 | 25 | |
| 19 | 2008 | 25 | |
| 20 | 2010 | 25 |
About Deborah Layton
Deborah Layton is a scholar working on Pharmacology, Toxicology, Cardiology and Cardiovascular Medicine, Pharmacology and Public Health, Environmental and Occupational Health, having authored 64 papers that have together received 1.1k indexed citations. Recurring topics across this work include Pharmacovigilance and Adverse Drug Reactions (15 papers), Inflammatory mediators and NSAID effects (11 papers), Pharmacogenetics and Drug Metabolism (3 papers), Pharmaceutical studies and practices (3 papers), Cardiac electrophysiology and arrhythmias (2 papers), Venous Thromboembolism Diagnosis and Management (2 papers), Advanced Causal Inference Techniques (2 papers) and Pharmaceutical industry and healthcare (2 papers). The work is most often cited by research in Toxicology (183 citations), Pharmacology (248 citations), Geriatrics and Gerontology (27 citations), Psychiatry and Mental health (104 citations) and Pharmacology (64 citations). Deborah Layton has collaborated with scholars based in United Kingdom, Netherlands and United States. Frequent co-authors include Saad Shakir, Lynda V. Wilton, Gillian Pearce, Emma Heeley, David W. J. Clark, Lynda Wilton, Scott Harris, Vicki Osborne, David W. Clark and A. Boshier. Their work appears in journals such as Drug Safety, Pharmacoepidemiology and Drug Safety, British Journal of Clinical Pharmacology, European Psychiatry and European Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.